Page last updated: 2024-08-24
plerixafor and exenatide
plerixafor has been researched along with exenatide in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, YD; Ma, Q; Yang, JJ; Zhang, Y; Zhou, H | 1 |
Reviews
1 review(s) available for plerixafor and exenatide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
1 other study(ies) available for plerixafor and exenatide
Article | Year |
---|---|
[Exenatide promotes chemotactic migration of adipose-derived stem cells through SDF-1/CXCR-4/Rho GTPase pathway].
Topics: Adipose Tissue; Anilides; Benzamides; Benzylamines; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Cyclams; Exenatide; Heterocyclic Compounds; Humans; Peptides; Receptors, CXCR4; rho GTP-Binding Proteins; Signal Transduction; Stem Cells; Venoms | 2016 |